Hila Magen

Dr. Hila Magen, MD

Head, Multiple Myeloma & Amyloidosis Unit – Sheba Medical Center

Leading Expert in Multiple Myeloma, Amyloidosis & Advanced Cellular Therapies

Dr. Hila Magen is a distinguished hemato-oncologist with over 35 years of experience, recognized as one of Israel’s leading experts in the treatment of multiple myeloma and complex plasma cell disorders.

As Head of the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center, she leads a highly specialized program focused on advanced, personalized therapies, including CAR-T cell treatment for high-risk patients.

Areas of Expertise

• Multiple Myeloma (Primary Focus)
• 
  Comprehensive management of relapsed, refractory, and high-risk myeloma
• Amyloidosis & Plasma Cell Disorders
  Advanced diagnosis and tailored treatment strategies
•  
• Advanced Cellular Therapies
•  
  • CAR-T Cell Therapy – principal investigator in innovative, point-of-care CAR-T programs
  • Integration of cutting-edge immunotherapies into clinical care
  •  
• Hematologic Malignancies
• 
  Lymphomas and complex blood disorders requiring precision treatment
•  

Clinical Leadership & Innovation

Dr. Magen leads one of the region’s most advanced units dedicated to myeloma and amyloidosis, focusing on:

• Personalized, targeted therapies
• Early access to innovative treatments and clinical trials
• Improving long-term outcomes and quality of life

She is actively involved in developing next-generation CAR-T therapies, offering patients access to some of the most advanced treatment options available worldwide.

International Training & Expertise

Dr. Magen completed advanced training at leading global institutions:

• Fellowship in Multiple Myeloma – University of Arkansas for Medical Sciences
• Fellowship in Lymphocytic Leukemia – MD Anderson Cancer Center

Leadership & Academic Roles

• Head, Multiple Myeloma & Amyloidosis Unit, Sheba Medical Center
• Instructor, Tel Aviv University
• Active contributor and speaker at international hematology conferences

Research & Recognition

• Author of 100+ scientific publications
• Contributor to landmark clinical studies in multiple myeloma treatment
• Active reviewer in international medical journals
•  

Clinical Approach

Dr. Magen is known for delivering highly personalized and innovative care, focusing on:

• Precision diagnosis and tailored treatment plans
• Combining standard therapies with cutting-edge innovations
• Supporting patients through complex, long-term treatment journeys

Patient-Centered Care

Dr. Magen provides compassionate, expert care, helping patients navigate complex diagnoses with access to world-class treatments, advanced technologies, and multidisciplinary support.

A Leader in Modern Myeloma Treatment

Through her leadership in CAR-T therapy, precision medicine, and advanced myeloma care, Dr. Magen offers patients access to one of the most specialized and advanced treatment programs globally.